|
| 37167915 | Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy. | J Colloid Interface Sci | 2023 |
| 35140411 | Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells. | Nat Protoc | 2022 |
| 34921580 | Analysis of multi-omics data on the relationship between epigenetic changes and nervous system disorders caused by exposure to environmentally harmful substances. | Environ Toxicol | 2022 |
| 34166773 | Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease. | Prog Neurobiol | 2021 |
| 33771089 | Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model. | J Enzyme Inhib Med Chem | 2021 |
| 33863993 | Brain cells derived from Alzheimer's disease patients have multiple specific innate abnormalities in energy metabolism. | Mol Psychiatry | 2021 |
| 34045367 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice. | Biomol Ther (Seoul) | 2021 |
| 32422864 | Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson's Disease. | Int J Mol Sci | 2020 |
| 31714896 | Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models. | J Clin Invest | 2020 |
| 32402162 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. | N Engl J Med | 2020 |
| 31495079 | HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice. | Exp Neurobiol | 2019 |
| 29706608 | Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription. | Aging (Albany NY) | 2018 |
| 29887985 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease. | Parkinsons Dis | 2018 |
| 29847726 | Cell-Penetrating Peptide-Patchy Deformable Polymeric Nanovehicles with Enhanced Cellular Uptake and Transdermal Delivery. | Biomacromolecules | 2018 |
| 30460108 | Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity. | Anim Cells Syst (Seoul) | 2018 |
| 28190238 | Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway. | Mol Neurobiol | 2018 |
| 27798112 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation. | Hum Mol Genet | 2017 |
| 28288000 | Age-associated chromatin relaxation is enhanced in Huntington's disease mice. | Aging (Albany NY) | 2017 |
| 28985749 | Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21<sup>WAF1/CIP1</sup> expression. | Mol Brain | 2017 |
| 28958936 | Suppression of neuroinflammation by matrix metalloproteinase-8 inhibitor in aged normal and LRRK2 G2019S Parkinson's disease model mice challenged with lipopolysaccharide. | Biochem Biophys Res Commun | 2017 |
| 25407931 | MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons. | Mol Neurobiol | 2016 |
| 27242267 | β-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes. | Free Radic Biol Med | 2016 |
| 27314038 | G2385R and I2020T Mutations Increase LRRK2 GTPase Activity. | Biomed Res Int | 2016 |
| 26944602 | Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice. | Neuroscience | 2016 |
| 25976370 | Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model. | Mol Neurobiol | 2016 |
| 25605758 | An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. | J Biochem | 2015 |
| 26384650 | Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression. | Mol Brain | 2015 |
| 26317805 | Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer's Disease. | PLoS One | 2015 |
| 26365310 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. | Nat Commun | 2015 |
| 26133660 | Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease. | Brain | 2015 |
| 25982323 | Reduction of Nfia gene expression and subsequent target genes by binge alcohol in the fetal brain. | Neurosci Lett | 2015 |
| 24333873 | Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice. | Biochem Biophys Res Commun | 2014 |
| 25478574 | Increased DJ-1 in urine exosome of Korean males with Parkinson's disease. | Biomed Res Int | 2014 |
| 25193078 | JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells. | Exp Cell Res | 2014 |
| 25086961 | Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology. | BMC Genomics | 2014 |
| 24559646 | miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling. | Neurobiol Aging | 2014 |
| 24607701 | Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. | Neurochem Int | 2014 |
| 24568732 | Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation. | Neuroscience | 2014 |
| 23949442 | LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25. | Exp Mol Med | 2013 |
| 24334988 | Development of electrochemical microbiochip for the biological diagnosis of Neisseria gonorrhoeae. | Anal Sci | 2013 |
| 24213601 | EPITRANS: a database that integrates epigenome and transcriptome data. | Mol Cells | 2013 |
| 22764206 | Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. | Sci Transl Med | 2012 |
| 20696760 | Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. | J Biol Chem | 2010 |
| 20698932 | The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome. | J Neurochem | 2010 |
| 19240033 | SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition. | J Biol Chem | 2009 |
| 18005339 | Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. | J Neurochem | 2008 |
| 18640989 | Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients. | Hum Mol Genet | 2008 |
| 17053214 | Efficient induction of oligodendrocytes from human embryonic stem cells. | Stem Cells | 2007 |
| 17600316 | Regulation of functional phenotypes of cord blood derived eosinophils by gamma-secretase inhibitor. | Am J Respir Cell Mol Biol | 2007 |
| 17327906 | Proteasome activator enhances survival of Huntington's disease neuronal model cells. | PLoS One | 2007 |